| A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy PG Komarov, EA Komarova, RV Kondratov, K Christov-Tselkov, JS Coon, ... Science 285 (5434), 1733-1737, 1999 | 1360 | 1999 |
| An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models LG Burdelya, VI Krivokrysenko, TC Tallant, E Strom, AS Gleiberman, ... Science 320 (5873), 226-230, 2008 | 735 | 2008 |
| The role of p53 in determining sensitivity to radiotherapy AV Gudkov, EA Komarova Nature Reviews Cancer 3 (2), 117-129, 2003 | 631 | 2003 |
| Suppression of the novel growth inhibitor p33 ING1 promotes neoplastic transformation I Garkavtsev, A Kazarov, A Gudkov, K Riabowol Nature genetics 14 (4), 415-420, 1996 | 508 | 1996 |
| The candidate tumour suppressor p33 ING1 cooperates with p53 in cell growth control I Garkavtsev, IA Grigorian, VS Ossovskaya, MV Chernov, PM Chumakov, ... Nature 391 (6664), 295-298, 1998 | 434 | 1998 |
| Structural basis of TLR5-flagellin recognition and signaling S Yoon, O Kurnasov, V Natarajan, M Hong, AV Gudkov, AL Osterman, ... Science 335 (6070), 859-864, 2012 | 430 | 2012 |
| Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53 SS Bacus, AV Gudkov, M Lowe, L Lyass, Y Yung, AP Komarov, ... Oncogene 20 (2), 147-155, 2001 | 413 | 2001 |
| Small-molecule inhibitor of p53 binding to mitochondria protects mice from gamma radiation E Strom, S Sathe, PG Komarov, OB Chernova, I Pavlovska, I Shyshynova, ... Nature chemical biology 2 (9), 474-479, 2006 | 349 | 2006 |
| Identification of a novel stress-responsive gene Hi95 involved in regulation of cell viability AV Budanov, T Shoshani, A Faerman, E Zelin, I Kamer, H Kalinski, ... Oncogene 21 (39), 6017-6031, 2002 | 328 | 2002 |
| Transgenic mice with p53‐responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo EA Komarova, MV Chernov, R Franks, K Wang, G Armin, CR Zelnick, ... The EMBO journal 16 (6), 1391-1400, 1997 | 322 | 1997 |
| The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway LG Korotchkina, OV Leontieva, EI Bukreeva, ZN Demidenko, AV Gudkov, ... Aging (Albany NY) 2 (6), 344, 2010 | 267 | 2010 |
| Paradoxical suppression of cellular senescence by p53 ZN Demidenko, LG Korotchkina, AV Gudkov, MV Blagosklonny Proceedings of the National Academy of Sciences 107 (21), 9660-9664, 2010 | 261 | 2010 |
| Circadian sensitivity to the chemotherapeutic agent cyclophosphamide depends on the functional status of the CLOCK/BMAL1 transactivation complex VY Gorbacheva, RV Kondratov, R Zhang, S Cherukuri, AV Gudkov, ... Proceedings of the National Academy of Sciences 102 (9), 3407-3412, 2005 | 257 | 2005 |
| BMAL1-dependent circadian oscillation of nuclear CLOCK: posttranslational events induced by dimerization of transcriptional activators of the mammalian clock system RV Kondratov, MV Chernov, AA Kondratova, VY Gorbacheva, AV Gudkov, ... Genes & development 17 (15), 1921-1932, 2003 | 251 | 2003 |
| Small molecules that reactivate p53 in renal cell carcinoma reveal a NF-κB-dependent mechanism of p53 suppression in tumors KV Gurova, JE Hill, C Guo, A Prokvolit, LG Burdelya, E Samoylova, ... Proceedings of the National Academy of Sciences 102 (48), 17448-17453, 2005 | 248 | 2005 |
| Regulation of NF-κB by NSD1/FBXL11-dependent reversible lysine methylation of p65 T Lu, MW Jackson, B Wang, M Yang, MR Chance, M Miyagi, AV Gudkov, ... Proceedings of the National Academy of Sciences 107 (1), 46-51, 2010 | 246 | 2010 |
| Dual effect of p53 on radiation sensitivity in vivo: p53 promotes hematopoietic injury, but protects from gastro-intestinal syndrome in mice EA Komarova, RV Kondratov, K Wang, K Christov, TV Golovkina, ... Oncogene 23 (19), 3265-3271, 2004 | 229 | 2004 |
| p53 is a suppressor of inflammatory response in mice EA Komarova, V Krivokrysenko, K Wang, N Neznanov, MV Chernov, ... The FASEB journal 19 (8), 1030-1032, 2005 | 226 | 2005 |
| Core circadian protein CLOCK is a positive regulator of NF-κB–mediated transcription ML Spengler, KK Kuropatwinski, M Comas, AV Gasparian, N Fedtsova, ... Proceedings of the National Academy of Sciences 109 (37), E2457-E2465, 2012 | 224 | 2012 |
| Levels of HdmX expression dictate the sensitivity of normal and transformed cells to Nutlin-3 JT Patton, LD Mayo, AD Singhi, AV Gudkov, GR Stark, MW Jackson Cancer research 66 (6), 3169-3176, 2006 | 215 | 2006 |
